TAS-05567

N/A

Report date: 2024/11/18 15:23:35
NME

Base Information

Drug NameTAS-05567
Drug Alias NameTAS-05567TAS-5567TAS-4335
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaiho Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPurpura, Thrombocytopenic, IdiopathicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A